LAWRENCE, Mass., Aug. 24, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that the NxStage® System One™ ...
NxStage Medical, Inc.NXTM recently announced the regulatory approval of its System One platform by the FDA for solo home hemodialysis treatment. The company has also announced that it will provide ...
LAWRENCE, Mass., Oct. 5, 2012 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today commented on a review article published on October 4 ...
SAN FRANCISCO (MarketWatch) -- NxStage Medical Inc. said late Wednesday it has received Food and Drug Administration 510(k) clearance to market its PureFlow SL product. This device is used to prepare ...
A key component of the Nx2me platform is the Nx2me iPad ® app, which is designed to increase patients' ease of use of home therapy by capturing treatment data and wirelessly sending it to their center ...
NxStage Medical, Inc.NXTM recently announced the receipt of CE mark for its NxGen Hemodialysis System, an innovative device with easier user interface and integrated blood pressure monitor system for ...
NxStage Medical Inc. of Lawrence has received U.S. Food and Drug Administration clearance to market its PureFlow SL product, a device that prepares high-purity dialysate from ordinary tap water in the ...
- "Our next generation system was developed with extensive patient and customer feedback and builds on our decade long experience in providing life-changing therapy with the NxStage® System One™ to ...
NxStage Medical, Inc. NXTM recently announced that its subsidiary NxStage Kidney Care is partnering Dialyze Direct for supporting the needs of patients who need on-site skilled-nursing facilities (SNF ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback